On Dec. 20, the Food and Drug Administration (FDA) expanded the approved use of Dexcom’s G5 Mobile Continuous Glucose Monitoring System to allow for replacement of fingerstick blood glucose testing for diabetes treatment decisions in people 2 years of age and older with diabetes. Read more . . .
On Dec. 19, the Food and Drug Administration (FDA) approved Rubraca (rucaparib) to treat women with advanced ovarian cancer who have been treated with two or more chemotherapies and whose tumors have the gene mutation deleterious BRCA as identified by an FDA-approved companion diagnostic test. Read more . . .
On Dec. 14, the Food and Drug Administration (FDA) released a safety communication warning that repeated or lengthy use of general anesthetic and sedation drugs during surgeries or procedures in children younger than 3 years or in pregnant women during their third trimester may affect the development of children’s . . .
On Dec. 2, the Food and Drug Administration (FDA) approved a new indication for Jardiance (empagliflozin) to reduce the risk of cardiovascular (CV) death in adult patients with type 2 diabetes mellitus and cardiovascular disease. Read more . . .
On Dec. 7, the Food and Drug Administration (FDA) issued a guidance document stating it does not intend to enforce the requirement that individuals 18 and up receive a medical evaluation or sign a waiver before purchasing most hearing aids and announced it will consider creating a category of over . . .
Thiazide diuretics used to treat hypertension may be associated with lower risk of hip and pelvic fractures compared with lisinopril or amlodipine, according to a study in JAMA Internal Medicine. Read more and access the article . . .
A study published in The Lancet reports that injections of methylprednisolone through the eardrum is as effective as gentamicin injections, but result in greater residual speech discrimination. Read more and access the article . . .
Researchers have developed an ultra long-lasting drug delivery system in the form of a capsule to deliver an anti-malaria drug, which could help eradicate the disease; the technique could also be used for delivery of other medicines. Access the full text in Science Translational Medicine . . .
On Oct. 19, the Food and Drug Administration (FDA) approved Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma. Read more . . .
On Oct. 28, the Food and Drug Administration (FDA) approved the Amplatzer PFO Occluder device, which reduces the risk of a stroke in patients who previously had a stroke believed to be caused by a blood clot passing through a patent foramen ovale and then travelling to the brain. Read . . .